Pharmacolog i Uppsala AB (publ) / Fundamentals

    Income statement

    Net revenue
    €598.73K
    Cost of goods sold
    €252.32K
    Gross profit
    €346.41K
    SG&A expenses
    €1.51M
    R&D expenses
    €0.00
    EBITDA
    -€996.09K
    D&A
    €11.65K
    EBIT
    -€1.11M
    Interest expenses
    €7.10K
    EBT
    -€1.09M
    Tax expenses
    €1.36K
    Net income
    -€1.09M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €24.39K
    Changes in working capital
    €55.05K
    Operating cash flow
    -€1.50M
    Capex
    €38.31K
    Other investing cash flow
    -€178.25K
    Net investing cash flow
    €619.11K
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €1.34M
    Debt repayment
    €0.00
    Other financing cash flow
    €1.11M
    Net financing cash flow
    €1.31M
    Foreign exchange effects
    €0.00
    Net change in cash
    €434.12K
    Cash at end of period
    €1.01M
    Free cash flow
    -€1.46M

    Balance sheet

    Cash and cash equivalents
    €1.01M
    Cash and short-term investments
    €1.01M
    Total receivables
    €0.00
    Inventory
    €65.88K
    Other current assets
    €0.00
    Total current assets
    €1.27M
    Property, plant & equipment
    €5.64K
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €0.00
    Total non-current assets
    €78.07K
    Total assets
    €1.35M
    Accounts payable
    €88.90K
    Short-term debt
    €0.00
    Other current liabilities
    -€65.24K
    Total current liabilities
    €218.29K
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €90.99
    Total liabilities
    €218.38K
    Common stock
    €98.73K
    Retained earnings
    €191.81K
    Other equity
    €0.00
    Total equity
    €1.13M
    Total liabilities and shareholders' equity
    €1.35M

    Company information

    Market capitalization
    €958.23K
    Employees
    10
    Enterprise Value
    -€407.93K

    Company ratios

    Gross margin
    57.9%
    EBITDA margin
    -166.4%
    EBIT margin
    -184.7%
    EBT margin
    -182.0%
    Net margin
    -181.6%
    ROE
    -96.2%
    ROA
    -80.6%
    Asset turnover
    44.4%
    FCF margin
    -256.5%
    FCF yield
    -160.3%
    Efficiency ratio
    266.4%
    Net sales per employee
    €59.87K
    Net income per employee
    -€108.74K

    Notifications